Search research articles

Search research articles

Related Experiment Videos

Endocrine disruptor risk characterization: an EPA perspective

P A Fenner-Crisp¹

¹Office of Pesticide Programs (7501C), U.S. Environmental Protection Agency, Washington, DC 20460, USA.

Regulatory Toxicology and Pharmacology : RTP

|August 1, 1997

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

FQPA science issues: common mechanism of toxicity and cumulative risk assessment.

Regulatory toxicology and pharmacology : RTP·2000

Same author

Endocrine modulators: risk characterization and assessment.

Toxicologic pathology·2000

Same author

Regulatory implications: U.S. Environmental Protection Agency.

Annals of the New York Academy of Sciences·1996

Same author

Impact of the Delaney Clause in the EPA.

Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie·1996

Same author

Pesticides--the NAS report: how can the recommendations be implemented?

Environmental health perspectives·1995

Same author

Evaluation of the carcinogenic potential of pesticides. 4. Chloroalkylthiodicarboximide compounds with fungicidal activity.

Regulatory toxicology and pharmacology : RTP·1993

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Characterizing risks from endocrine-disrupting chemicals (EDCs) is challenging due to complex endocrine system interactions and developmental timing. Current risk assessment methods for hormonally mediated effects need adaptation as scientific understanding grows.

Area of Science:

Endocrinology
Toxicology
Risk Assessment

Background:

The endocrine system is a complex network of interacting systems with cyclical functions.
Assessing risks of endocrine-disrupting agents presents significant challenges for regulatory bodies.
Understanding the impact of timing and developmental stage on endocrine disruption is crucial.

Purpose of the Study:

To highlight the complexities in characterizing risks associated with endocrine-disrupting agents.
To review current practices for assessing hormonally mediated cancer and non-cancer effects.
To propose potential modifications to risk characterization approaches.

Main Methods:

Discussion of current risk assessment practices for endocrine disruptors.
Analysis of the unique challenges posed by the endocrine system's complexity.

Related Experiment Videos

Speculation on future adaptations based on evolving scientific knowledge.

Main Results:

Endocrine disruption risk assessment is complicated by system interdependencies and timing-dependent effects.
Concomitant exposures to endocrine-active substances are poorly understood.
Existing methods for cancer and non-cancer risk characterization require re-evaluation.

Conclusions:

Risk characterization of endocrine-disrupting agents demands novel approaches.
Adapting current methodologies is essential to address the intricate nature of endocrine disruption.
Further research is needed to refine risk assessment strategies for these agents.